5.4855

0.74% 0.0955

Adapthealth Corp (AHCO)

Overview News Price History Option Chain Financials Why AHCO Down? Discussions Forecast

Adapthealth Corp stock is traded at $5.4855, with a volume of 116.52K. It is up +0.74% in the last 24 hours and down -51.56% over the past month. AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.

Previous Close:

$5.39

Open:

$5.41

24h Volume:

116.52K

Relative Volume:

0.05

Market Cap:

$729.08M

Revenue:

$3.24B

Net Income/Loss:

$-66.64M

P/E Ratio:

-10.33

EPS:

-0.5308

Net Cash Flow:

$219.38M

1W Performance:

-6.54%

1M Performance:

-51.56%

6M Performance:

-47.49%

1Y Performance:

-41.74%

1-Day Range:

$5.36

$5.50

1-Week Range:

$5.32

$5.95

52-Week Range:

$5.21

$13.43

Adapthealth Corp Stock (AHCO) Company Profile

Name

Adapthealth Corp

Sector

Healthcare (1083)

Industry

Medical Devices (140)

Phone

610-424-4515

Address

555 EAST NORTH LANE, CONSHOHOCKEN, PA

Employee

10,900

Twitter

Next Earnings Date

2026-08-04

Latest SEC Filings

AHCO's Discussions on Twitter

Compare AHCO vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
AHCO Adapthealth Corp	5.465	755.10M	3.24B	-66.64M	219.38M	-0.5308
ABT Abbott Laboratories	114.56	198.01B	46.59B	5.41B	7.38B	3.0938
SYK Stryker Corp	330.92	130.41B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	92.21	120.48B	36.36B	4.84B	5.43B	3.7261
BSX Boston Scientific Corp	49.51	75.37B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	89.54	53.19B	6.30B	1.07B	1.09B	1.8406

Adapthealth Corp Stock (AHCO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-08-24	Downgrade	Jefferies	Buy → Hold
Nov-08-23	Downgrade	BofA Securities	Neutral → Underperform
May-10-23	Downgrade	Deutsche Bank	Buy → Hold
May-10-23	Downgrade	Stifel	Buy → Hold
May-09-23	Downgrade	BofA Securities	Buy → Neutral
Sep-27-21	Initiated	SVB Leerink	Outperform
Jul-14-21	Upgrade	Robert W. Baird	Neutral → Outperform
Apr-13-21	Downgrade	Robert W. Baird	Outperform → Neutral
Mar-18-21	Initiated	Truist	Buy
Jan-26-21	Initiated	BofA Securities	Buy
Dec-10-20	Initiated	UBS	Buy
Aug-10-20	Initiated	Canaccord Genuity	Buy
Jul-01-20	Resumed	SVB Leerink	Outperform
Jun-09-20	Initiated	RBC Capital Mkts	Outperform
Jan-31-20	Initiated	Stifel	Buy
Jan-07-20	Initiated	Jefferies	Buy
Dec-11-19	Initiated	SVB Leerink	Outperform
Dec-10-19	Initiated	Deutsche Bank	Buy

View All

Adapthealth Corp Stock (AHCO) Latest News

Aug 20, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating AdaptHealth Corp. (AHCO) And Encourages Shareholders to Connect - ACCESS Newswire

Aug 20, 2026

Aug 19, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating AdaptHealth C - The National Law Review

Aug 19, 2026

AdaptHealth (NASDAQ:AHCO) Faces Pressure After Weak Quarterly Results - Kalkine Media

Aug 19, 2026

AdaptHealth breach exposed health records of one in 13 Vermonters - Vermont Daily Chronicle

Aug 19, 2026

AdaptHealth Breach Exposed Health Records of One in 13 Vermonters - Compass Vermont

Aug 19, 2026

AdaptHealth Corp. (NASDAQ:AHCO) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Aug 19, 2026

Aug 18, 2026

AdaptHealth's Market Cap Drops To US$696m Leaving Insiders With Losses - 富途牛牛

Aug 18, 2026

Aug 17, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against AdaptHealth Corp. (AHCO) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Aug 17, 2026